Immunofusion
ActiveSummary
The computed 12-month bankruptcy probability of Immunofusion is 3.5% (moderate). The 2025 annual accounts show negative equity (-€126,049) and a net result of -€42,606. Equity is shrinking by about 69% per year across the filed financial years. Its solvency ranks better than 5% of 271 sector peers (NACE 72, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Activités scientifiques; Recherche et développement en oncologie et hématologie pour la mise au point de nouveaux médicaments; Recherche et…” (deed in Dutch)
6 activities (deed in Dutch)
- Activités scientifiques.
- Recherche et développement en oncologie et hématologie pour la mise au point de nouveaux médicaments.
- Recherche et développement de substances actives destinées à la fabrication de médicaments.
- Fabrication de médicaments.
- Travaux de laboratoire.
- Études scientifiques,rapports et publications.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- [MMUNOFUSION
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne, annexe au Moniteur Belge par l'organe d'administration” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Article 13: Représentation de la société L'administrateur (chacun des administrateurs) représente la société à l'égard des tiers et en…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Un ou plusieurs administrateurs, organe d'administration” (deed in Dutch)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- One provision in the deed
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Thursday of June at 18:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “En tout temps, assemblée générale” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Dissolution pour quelque cause et à quelque moment que ce soit, le ou les liquidateurs” (deed in Dutch)